Literature DB >> 1616853

Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.

J Bedwell1, A J MacRobert, D Phillips, S G Bown.   

Abstract

Aminolaevulinic acid (ALA) is the first committed step in haem synthesis. In the presence of excess ALA the natural regulatory feedback system is disrupted allowing accumulation of protoporphyrin IX (PP IX) the last intermediate product before haem, and an effective sensitiser. This method of endogenous photosensitisation of cells has been exploited for photodynamic therapy (PDT). We have studied the fluorescence distribution and biological effect of induced PP IX in normal and tumour tissue in the rat colon. Fluorescence in normal colonic tissue was at a peak of 4 h with a rapid fall off by 6 h. The fluorescence had returned to background levels by 24 h. All normal tissue layers followed the same fluorescence profile but the mucosa showed fluorescent levels six times higher than the submucosa, with muscle barely above background values. At 6 h the ratio of fluorescence levels between normal mucosa and viable tumour was approximately 1:6. At this time laser treatment showed necrosis of normal mucosa and tumour with sparing of normal muscle. There was good correlation between the fluorescence distribution and the biological effect of ALA-induced photosensitisation on exposure to red light. ALA may be superior to conventional sensitisers for tumours that produce haem as the PP IX is synthesised in malignant cells while the other sensitisers mainly localise to the vascular stroma of tumours. There is also a greater concentration difference between the PP IX levels in tumours and in normal mucosa and normal muscle than with the other photosensitisers raising the possibility of more selective necrosis in tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616853      PMCID: PMC1977757          DOI: 10.1038/bjc.1992.175

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  HEPATIC PORPHYRIA AND DRUG-INDUCED OR CHEMICAL PORPHYDRIA.

Authors:  S GRANICK
Journal:  Ann N Y Acad Sci       Date:  1965-03-12       Impact factor: 5.691

2.  Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin.

Authors:  G L Zalar; M Poh-Fitzpatrick; D L Krohn; R Jacobs; L C Harber
Journal:  Arch Dermatol       Date:  1977-10

3.  5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells.

Authors:  Z Malik; M Djaldetti
Journal:  Cell Differ       Date:  1979-06

4.  The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization.

Authors:  A J Pope; S G Bown
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

5.  Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue.

Authors:  H Barr; P Chatlani; C J Tralau; A J MacRobert; P B Boulos; S G Bown
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

6.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

Authors:  J C Kennedy; R H Pottier; D C Pross
Journal:  J Photochem Photobiol B       Date:  1990-06       Impact factor: 6.252

7.  Fluorimetric study of the binding of protoporphyrin to haemopexin and albumin.

Authors:  A A Lamola; I Asher; U Muller-Eberhard; M Poh-Fitzpatrick
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

8.  Use of charge coupled device camera for imaging of intracellular phthalocyanines.

Authors:  W S Chan; A J MacRobert; D Phillips; I R Hart
Journal:  Photochem Photobiol       Date:  1989-11       Impact factor: 3.421

9.  Experimental porphyric neuropathy: a preliminary report.

Authors:  A A Sima; J C Kennedy; D Blakeslee; D M Robertson
Journal:  Can J Neurol Sci       Date:  1981-05       Impact factor: 2.104

10.  Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study.

Authors:  M I Filipe
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  45 in total

1.  Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?

Authors:  R Ackroyd; N J Brown; T J Stephenson; C J Stoddard; M W Reed
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

2.  Enhancement of photodynamic therapy in gastric cancer cells by removal of iron.

Authors:  W C Tan; N Krasner; P O'Toole; M Lombard
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.

Authors:  R Bachor; E Reich; A Rück; R Hautmann
Journal:  Urol Res       Date:  1996

4.  Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies.

Authors:  Johannes Gahlen; Ruediger L Prosst; Matthias Pietschmann; Thomas Haase; Markus Rheinwald; Gisela Skopp; Josef Stern; Christian Herfarth
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

5.  Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience.

Authors:  C Ell; L Gossner; A May; H T Schneider; E G Hahn; M Stolte; R Sroka
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

6.  Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins.

Authors:  K Orth; K König; F Genze; A Rück
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

7.  Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma.

Authors:  Bashar J Qumseya; Waseem David; Herbert C Wolfsen
Journal:  Clin Endosc       Date:  2013-01-31

8.  Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas.

Authors:  S G Smith; J Bedwell; A J MacRobert; M H Griffiths; S G Bown; M R Hetzel
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

9.  Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.

Authors:  J Regula; A J MacRobert; A Gorchein; G A Buonaccorsi; S M Thorpe; G M Spencer; A R Hatfield; S G Bown
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

10.  Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.

Authors:  C J Kelty; R Ackroyd; N J Brown; S B Brown; M W R Reed
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.